Clinical Trials Directory

Trials / Completed

CompletedNCT01763060

Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure

Status
Completed
Phase
Study type
Observational
Enrollment
7 (actual)
Sponsor
Karolinska University Hospital · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers

Summary

Patients treated with Extracorporeal Membrane Oxygenation (ecmo) for severe respiratory or circulatory failure show severe long term disability due to impaired lung -, cerebral-, cognitive function and impaired quality of life. This study investigates the long term outcome of all patients who are still alive three years after ECMO treatment for severe respiratory failure during the H1N1 2009 pandemic at the Karolinska University Hospital.

Conditions

Interventions

TypeNameDescription
RADIATIONCT scan
BEHAVIORALCognitive function
RADIATIONMRI

Timeline

Start date
2012-10-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2013-01-08
Last updated
2013-11-21

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01763060. Inclusion in this directory is not an endorsement.